[Clinical practice guidelines for assessment and treatment of transsexualism. SEEN Identity and Sexual Differentiation Group (GIDSEEN)]

Endocrinol Nutr. 2012 Jun-Jul;59(6):367-82. doi: 10.1016/j.endonu.2012.02.001. Epub 2012 Apr 26.
[Article in Spanish]

Abstract

Transsexual patients can only be diagnosed and treated at functional gender identity Units with provision of high quality care, development of clinical practice guidelines, and interdisciplinary working groups. The therapeutic process has three mainstays: initial psychological diagnostic evaluation and psychotherapy, endocrinological evaluation and hormone therapy, and sex reassignment surgery. Cross-sex hormone therapy is essential for the anatomical and psychological transition process in duly selected patients. Hormones help optimize real-life sex identity, improve quality of life, and limit psychiatric co-morbidities often associated to lack of treatment. Development of this clinical practice guideline addresses the need for implementing a coordinated action protocol for comprehensive health care for transgender people in the National Health System.

Publication types

  • English Abstract
  • Practice Guideline

MeSH terms

  • Female
  • Humans
  • Male
  • Transsexualism / diagnosis*
  • Transsexualism / therapy*